325 related articles for article (PubMed ID: 20701441)
21. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
Smith L; Lind MJ; Welham KJ; Cawkwell L;
Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in biomarkers for cancer diagnosis and treatment.
Manne U; Srivastava RG; Srivastava S
Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
[TBL] [Abstract][Full Text] [Related]
23. [Genomic markers and anticancer chemotherapy].
Nishiyama M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
[TBL] [Abstract][Full Text] [Related]
24. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
Tomaszek SC; Huebner M; Wigle DA
Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
[TBL] [Abstract][Full Text] [Related]
25. Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine.
Blokzijl A; Friedman M; Pontén F; Landegren U
J Intern Med; 2010 Sep; 268(3):232-45. PubMed ID: 20695973
[TBL] [Abstract][Full Text] [Related]
26. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
Watson AP; Egland KA
S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
[TBL] [Abstract][Full Text] [Related]
27. Using gene expression profiling to predict response and prognosis in gastrointestinal cancers-the promise and the perils.
Brettingham-Moore KH; Duong CP; Heriot AG; Thomas RJ; Phillips WA
Ann Surg Oncol; 2011 May; 18(5):1484-91. PubMed ID: 21104326
[TBL] [Abstract][Full Text] [Related]
28. Digitization and its discontents: future shock in predictive oncology.
Epstein RJ
Semin Oncol; 2010 Feb; 37(1):60-4. PubMed ID: 20172366
[TBL] [Abstract][Full Text] [Related]
29. [Clinical trials and personalized medicine in oncology?].
Arnold D; Bokemeyer C
Onkologie; 2010; 33 Suppl 7():25-9. PubMed ID: 20926911
[TBL] [Abstract][Full Text] [Related]
30. Renal cell carcinoma and proteomics.
Sandim V; Pereira DA; Ornellas AA; Alves G
Urol Int; 2010; 84(4):373-7. PubMed ID: 20224258
[TBL] [Abstract][Full Text] [Related]
31. [Omics docking and molecular classification in colorectal cancer].
Peng Y; Shen S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1201-6. PubMed ID: 21131745
[TBL] [Abstract][Full Text] [Related]
32. Translational medicine promising personalized therapy in oncology.
Zeng YX; Zhang XS; Liu Q
Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
[No Abstract] [Full Text] [Related]
33. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.
Anderson JE; Hansen LL; Mooren FC; Post M; Hug H; Zuse A; Los M
Drug Resist Updat; 2006; 9(4-5):198-210. PubMed ID: 17011811
[TBL] [Abstract][Full Text] [Related]
34. Serum biomarker profiling in cancer studies: a question of standardisation?
Matharoo-Ball B; Miles AK; Creaser CS; Ball G; Rees R
Vet Comp Oncol; 2008 Dec; 6(4):224-47. PubMed ID: 19178682
[TBL] [Abstract][Full Text] [Related]
35. The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.
Cloonan N; Waddell N; Grimmond SM
IDrugs; 2010 Nov; 13(11):778-81. PubMed ID: 21046525
[TBL] [Abstract][Full Text] [Related]
36. The search for optimal response prediction in cancer leads to a personalized approach.
Van Cutsem E; Ciardiello F
Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
[No Abstract] [Full Text] [Related]
37. Challenges for biomarkers in cancer detection.
Wagner PD; Verma M; Srivastava S
Ann N Y Acad Sci; 2004 Jun; 1022():9-16. PubMed ID: 15251933
[TBL] [Abstract][Full Text] [Related]
38. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
39. Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products.
Efferth T
Planta Med; 2010 Aug; 76(11):1143-54. PubMed ID: 20486071
[TBL] [Abstract][Full Text] [Related]
40. Interpretation of treatment results with biological agents: is there a need for a new methodology?
Begent RH
J BUON; 2007 Sep; 12 Suppl 1():S53-8. PubMed ID: 17935278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
